Liraglutide vs Tibolone: side-by-side comparison
Liraglutide (GLP-1 receptor agonist) and Tibolone (Synthetic steroid (STEAR)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Liraglutide | Tibolone |
|---|---|---|
| Therapeutic class | GLP-1 receptor agonist | Synthetic steroid (STEAR) |
| CAS | 204656-20-2 | 5630-53-5 |
| ATC | A10BJ02 | G03CX01 |
| Molecular weight | 3751.2 g/mol | 312.45 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Liraglutide and Tibolone share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Liraglutide acts by a different mechanism than Tibolone, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Liraglutide: Liraglutide binds and activates the GLP-1 receptor in pancreatic beta and alpha cells, the central nervous system and the gastrointestinal tract. Tibolone: Tibolone is a prodrug; on absorption it is rapidly converted to three active metabolites (3α-OH-tibolone, 3β-OH-tibolone and Δ4-tibolone) with different tissue-selective activity.
Indications compared
Liraglutide: Liraglutide is approved in adults with type 2 diabetes mellitus, alone or in combination with other antidiabetic agents, to improve glycaemic control. Tibolone: Tibolone is approved (in countries where licensed) for treatment of moderate-to-severe vasomotor menopausal symptoms and prevention of postmenopausal osteoporosis in women at least 12 months past their last natural menst…
Safety profile
Liraglutide: The most common adverse effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, generally mild to moderate and most pronounced during the initial dose escalation. Tibolone: Common adverse effects include vaginal bleeding or spotting (especially in the first 3 months), breast tenderness, weight changes, headache and dizziness.
Frequently asked questions
Is Liraglutide better than Tibolone? ▾
Liraglutide and Tibolone are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Liraglutide and Tibolone be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Liraglutide
Products with Tibolone
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.